カイノスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/04/12 | 1,228 | 1,228 | 1,200 | 1,218 | -2 | -0.2% | 6,300 |
| 2024/04/11 | 1,214 | 1,228 | 1,208 | 1,220 | ±0 | ±0% | 2,100 |
| 2024/04/10 | 1,231 | 1,232 | 1,218 | 1,220 | -11 | -0.9% | 3,100 |
| 2024/04/09 | 1,217 | 1,240 | 1,210 | 1,231 | +1 | +0.1% | 3,200 |
| 2024/04/08 | 1,220 | 1,230 | 1,204 | 1,230 | +10 | +0.8% | 6,900 |
| 2024/04/05 | 1,219 | 1,220 | 1,193 | 1,220 | ±0 | ±0% | 6,400 |
| 2024/04/04 | 1,190 | 1,220 | 1,190 | 1,220 | +31 | +2.6% | 6,000 |
| 2024/04/03 | 1,186 | 1,194 | 1,161 | 1,189 | +1 | +0.1% | 4,100 |
| 2024/04/02 | 1,185 | 1,192 | 1,173 | 1,188 | +2 | +0.2% | 2,300 |
| 2024/04/01 | 1,197 | 1,198 | 1,160 | 1,186 | -11 | -0.9% | 9,300 |
| 2024/03/29 | 1,202 | 1,217 | 1,191 | 1,197 | -12 | -1% | 4,700 |
| 2024/03/28 | 1,220 | 1,221 | 1,181 | 1,209 | -13 | -1.1% | 5,000 |
| 2024/03/27 | 1,238 | 1,238 | 1,220 | 1,222 | -13 | -1.1% | 4,100 |
| 2024/03/26 | 1,249 | 1,249 | 1,205 | 1,235 | -3 | -0.2% | 8,700 |
| 2024/03/25 | 1,218 | 1,289 | 1,213 | 1,238 | +18 | +1.5% | 69,600 |
| 2024/03/22 | 1,213 | 1,220 | 1,194 | 1,220 | +10 | +0.8% | 11,300 |
| 2024/03/21 | 1,206 | 1,219 | 1,183 | 1,210 | +5 | +0.4% | 4,700 |
| 2024/03/19 | 1,219 | 1,219 | 1,176 | 1,205 | -3 | -0.2% | 4,500 |
| 2024/03/18 | 1,198 | 1,231 | 1,198 | 1,208 | -2 | -0.2% | 5,900 |
| 2024/03/15 | 1,174 | 1,212 | 1,173 | 1,210 | +32 | +2.7% | 12,200 |
| 2024/03/14 | 1,173 | 1,178 | 1,173 | 1,178 | ±0 | ±0% | 500 |
| 2024/03/13 | 1,173 | 1,183 | 1,173 | 1,178 | +2 | +0.2% | 3,300 |
| 2024/03/12 | 1,184 | 1,184 | 1,173 | 1,176 | -4 | -0.3% | 1,700 |
| 2024/03/11 | 1,182 | 1,193 | 1,172 | 1,180 | -14 | -1.2% | 3,800 |
| 2024/03/08 | 1,186 | 1,194 | 1,177 | 1,194 | +6 | +0.5% | 2,600 |
| 2024/03/07 | 1,198 | 1,198 | 1,181 | 1,188 | -6 | -0.5% | 5,000 |
| 2024/03/06 | 1,166 | 1,195 | 1,166 | 1,194 | +22 | +1.9% | 9,900 |
| 2024/03/05 | 1,165 | 1,172 | 1,161 | 1,172 | +9 | +0.8% | 1,300 |
| 2024/03/04 | 1,175 | 1,175 | 1,160 | 1,163 | ±0 | ±0% | 7,000 |
| 2024/03/01 | 1,152 | 1,176 | 1,150 | 1,163 | +12 | +1% | 6,500 |
| 2024/02/29 | 1,166 | 1,166 | 1,151 | 1,151 | -1 | -0.1% | 2,600 |
| 2024/02/28 | 1,149 | 1,153 | 1,146 | 1,152 | +2 | +0.2% | 1,500 |
| 2024/02/27 | 1,155 | 1,155 | 1,146 | 1,150 | +1 | +0.1% | 5,100 |
| 2024/02/26 | 1,156 | 1,156 | 1,145 | 1,149 | -4 | -0.3% | 5,000 |
| 2024/02/22 | 1,150 | 1,155 | 1,144 | 1,153 | +11 | +1% | 5,800 |
| 2024/02/21 | 1,146 | 1,150 | 1,138 | 1,142 | -4 | -0.3% | 2,200 |
| 2024/02/20 | 1,144 | 1,155 | 1,144 | 1,146 | +2 | +0.2% | 2,400 |
| 2024/02/19 | 1,133 | 1,149 | 1,133 | 1,144 | +12 | +1.1% | 8,300 |
| 2024/02/16 | 1,128 | 1,132 | 1,118 | 1,132 | +10 | +0.9% | 5,100 |
| 2024/02/15 | 1,146 | 1,147 | 1,118 | 1,122 | -24 | -2.1% | 20,900 |
| 2024/02/14 | 1,143 | 1,157 | 1,143 | 1,146 | -7 | -0.6% | 5,400 |
| 2024/02/13 | 1,144 | 1,155 | 1,143 | 1,153 | +9 | +0.8% | 2,900 |
| 2024/02/09 | 1,152 | 1,157 | 1,144 | 1,144 | -8 | -0.7% | 5,700 |
| 2024/02/08 | 1,167 | 1,167 | 1,150 | 1,152 | -15 | -1.3% | 6,800 |
| 2024/02/07 | 1,165 | 1,169 | 1,160 | 1,167 | +1 | +0.1% | 9,000 |
| 2024/02/06 | 1,183 | 1,183 | 1,165 | 1,166 | -17 | -1.4% | 5,800 |
| 2024/02/05 | 1,181 | 1,192 | 1,176 | 1,183 | -10 | -0.8% | 4,700 |
| 2024/02/02 | 1,178 | 1,193 | 1,173 | 1,193 | +13 | +1.1% | 6,200 |
| 2024/02/01 | 1,177 | 1,185 | 1,175 | 1,180 | -13 | -1.1% | 6,900 |
| 2024/01/31 | 1,190 | 1,194 | 1,175 | 1,193 | +7 | +0.6% | 5,700 |
151～
200
件表示中 / 3585件
類似銘柄と比較する
現在ご覧いただいている「カイノス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| カイノス | 120,300円 | +6.8% | -13.8% | 2.66% | 9.22倍 | 0.78倍 |
|
臨床検査薬の中堅メーカー。生化学、免疫血清学的検査用試薬に重点。共同開発の促進に注力 |
| ＶＩＳ | 90,500円 | +87.8% | +265.7% | 0.00% | 54.35倍 | 2.49倍 |
|
ｍＲＮＡ標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
| クリングル | 86,000円 | +240.0% | - | 0.00% | - | 2.80倍 |
|
細胞の増殖、保護、修復などの機能があるＨＧＦタンパク質を用いて、難治性疾患治療薬を開発 |
| キッズバイオ | 11,800円 | - | - | 0.00% | - | 6.21倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞（ＳＨＥＤ）用いた再生医療に力 |
| ＤＥＬＴＡ－Ｐ | 52,300円 | - | - | 0.00% | - | 15.01倍 |
|
創薬ベンチャー。既存の抗がん物質を組み合わせて安全性と有効性を高めた抗がん剤を開発 |
市場注目の銘柄
チャート関連のコラム
